Abstract
Sjögren’s syndrome (SS) is a chronic, systemic autoimmune disorder affecting predominantly middle-aged females. SS clinical manifestations can be related to glandular dysfunction (keratoconjunctivitis sicca, oral dryness, bronchitis sicca, parotid gland enlargement) and extra-glandular/systemic involvement. The latter is either due to peri-epithelial infiltrates in parenchymal organs (small airway disease, interstitial nephritis, biliary cirrhosis) or due to immune complex deposition (palpable purpura, peripheral neuropathy, glomerulonephritis, systemic vasculitis). In the majority of patients, SS runs an indolent benign course. In a small yet not negligible number of cases (5–10%), SS is complicated by lymphoid neoplasia. Sicca manifestations, increased fatigability, arthralgias/myalgias, nonerosive arthritis, Raynaud’s phenomenon (RP), and signs of renal tubular acidosis may be initial manifestations of SS. After excluding other causes of sicca symptomatology, patients should be assessed for lacrimal and salivary gland function (ocular staining with lissamine green or rose bengal, Schirmer’s test and unstimulated saliva secretion, respectively), and a biopsy of labial minor salivary glands should be performed to evaluate the presence of lymphocytic infiltrates around salivary gland epithelium. SS patients presenting salivary gland enlargement, Raynaud’s phenomenon, lymphadenopathy, anti-Ro/SSA or anti-La/SSB autoantibodies, rheumatoid factor positivity, monoclonality, and low serum C4 levels should be monitored closely, since these clinical, laboratory, and immunologic parameters have been shown to be independent predictors for non-Hodgkin’s lymphoma development.
IgG4-related disease (IgG4-RD) has recently emerged as a new clinical entity. It comprises numerous conditions previously thought to be unrelated, such as sclerosing dacryoadenitis/orbital pseudotumor, sialadenitis, autoimmune pancreatitis, retroperitoneal fibrosis/periaortitis, sclerosing cholangitis, Riedel thyroiditis, hypophysitis, and prostatitis. IgG4-RDs are clinically characterized by tumor-like lesions in affected organs. Histopathologically, they typically present lymphoplasmacytic infiltrates with increased IgG4+ plasma cells, storiform fibrosis, obliterative phlebitis, and tissue eosinophilia, while serum IgG4 concentration is usually increased. Typically IgG4RD symptoms respond promptly to steroids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. J Autoimmun. 2010;34:400–7. https://doi.org/10.1016/j.jaut.2009.10.004.
Moutsopoulos HM. Sjögren’s syndrome: a forty-year scientific journey. J Autoimmun. 2014;51:1–9. https://doi.org/10.1016/j.jaut.2014.01.001.
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al; International Sjögren’s Syndrome Criteria Working Group. American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76:9–16. https://doi.org/10.1136/annrheumdis-2016-210571.
Mavragani CP, Moutsopoulos HM. Sjögren syndrome. CMAJ. 2014;186:E579–86. https://doi.org/10.1503/cmaj.122037.
Fragkioudaki S, Mavragani CP, Moutsopoulos HM. Predicting the risk for lymphoma development in Sjogren syndrome: an easy tool for clinical use. Medicine (Baltimore). 2016;95:e3766. https://doi.org/10.1097/MD.0000000000003766.
Vlachoyiannopoulos PG, Moutsopoulos HM. Anticentromere (ACA)-positive Sjögren’s syndrome: a disease entity? Clin Exp Rheumatol. 2013;31:163–4.
Goules AV, Tatouli IP, Moutsopoulos HM, Tzioufas AG. Clinically significant renal involvement in primary Sjögren’s syndrome: clinical presentation and outcome. Arthritis Rheum. 2013;65:2945–53. https://doi.org/10.1002/art.38100.
Wallace ZS, Deshpande V, Mattoo H, Mahajan VS, Kulikova M, et al. IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol. 2015;67:2466–75. https://doi.org/10.1002/art.39205.
Fragoulis GE, Zampeli E, Moutsopoulos HM. IgG4-related sialadenitis and Sjögren’s syndrome. Oral Dis. 2017;23:152–6. https://doi.org/10.1111/odi.12526.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Moutsopoulos, H.M., Zampeli, E., Vlachoyiannopoulos, P.G. (2018). Sjögren’s Syndrome, IgG4-Related Disorders. In: Rheumatology in Questions. Springer, Cham. https://doi.org/10.1007/978-3-319-71604-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-71604-6_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-71603-9
Online ISBN: 978-3-319-71604-6
eBook Packages: MedicineMedicine (R0)